throbber
PDL's Humanized Antibody Technology
`
`https://web.archive.org/web/20000303232942/http://www.pdl.com/Guid...
`
`The human body naturally produces millions of antibodies, proteins that fight disease by binding to specific targets on the surfaces of
`bacteria or viruses. In the 1970s, scientists first developed techniques to immunize mice with a foreign organism and clone (isolate)
`and grow single cells that pump out antibodies against the intruder. Despite their initial promise, these mouse monoclonal antibodies
`have fallen short as therapeutics. They are rapidly eliminated from the body and so must be infused into patients almost daily. More
`important, the body's own antibodies mount an immune reaction (known as a human anti-mouse antibody or HAMA response) against
`the mouse antibody, rendering it ineffective for further therapy.
`
`To overcome these limitations, PDL uses computer modeling and genetic engineering to convert mouse antibodies into human-like
`SMART (TM) Antibodies.
`
`DNA from cells producing a mouse antibody is isolated and placed in a sequencing machine to determine the chemical structure of the
`genes that encode the antibody. Using the genetic code, the amino acids composing the antibody itself are then determined.
`
`Proprietary computer software compares the amino acid sequence of the mouse antibody to the sequences of antibodies whose
`structure has been determined using X-ray diffraction, and then builds a 3-dimensional model of the key part of the mouse antibody.
`
`Click Here to see a computer modeling demonstration of PDL's humanization strategy.
`
`1 of 3
`
`12/28/2014 5:40 PM
`
`IMMUNOGEN 2083, pg. 1
`Phigenix v. Immunogen
`IPR2014-00676
`
`

`

`PDL's Humanized Antibody Technology
`
`https://web.archive.org/web/20000303232942/http://www.pdl.com/Guid...
`
`The minimum number of mouse amino acids (shown in red and dark blue) identified as necessary for binding to the target are
`combined with amino acids from a human antibody (light blue).
`
`The chemical structure of the genes to make the new SMART Antibody are programmed into a DNA synthesizer to synthesize the
`genes.
`
`The genes are inserted into a mammalian cell, which produces the antibody. In the lab, a humanized anti-herpes antibody blocks the
`virus from spreading from infected cells (dark spots, left); without the antibody, the virus infects all cells (right).
`
`Additional Technologies:
`Human Antibodies
`
`Novel Antibiotics
`
`Small Molecules
`
`Additional
`Information:
`
`2 of 3
`
`12/28/2014 5:40 PM
`
`IMMUNOGEN 2083, pg. 2
`Phigenix v. Immunogen
`IPR2014-00676
`
`

`

`PDL's Humanized Antibody Technology
`
`https://web.archive.org/web/20000303232942/http://www.pdl.com/Guid...
`
`I N T lll'l lf At C t0\11
`
`ma~unehmoo~m~
`
`5 captures
`27 Jan 00 - 8 Jan 01
`
`Go
`
`JAN
`~
`1999
`
`JUN
`
`...
`
`2001 ~
`
`3 of 3
`
`12/28/2014 5:40 PM
`
`IMMUNOGEN 2083, pg. 3
`Phigenix v. Immunogen
`IPR2014-00676
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket